DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
State-administered coverage for low-income Americans
Medicaid is jointly funded by federal and state governments but administered by individual states. GLP-1 coverage varies dramatically by state. As of 2026, about 13 states cover weight-loss GLP-1s on their Medicaid formularies; diabetes indications are covered nationwide.
Medicaid coverage of weight-loss GLP-1s as of 2026: 13 states cover with PA (CA, CT, DE, MA, MI, MN, MO, NJ, NY, OR, PA, RI, VA). All states cover diabetes-indicated GLP-1s. Compounded versions usually not covered. Income-based eligibility plus state-specific PA requirements apply.
Sample copays based on a representative Medicaid (national overview) plan. Your specific plan may differ.
| Product | Status | Sample copay |
|---|---|---|
| Hims & Hers Weight Loss | Not covered | — |
| Mounjaro T2D diagnosis | Covered | $2/mo |
| Ozempic T2D diagnosis. Nominal copay or $0 depending on state. | Covered | $2/mo |
| Zepbound Same states as Wegovy plus OSA + obesity coverage expanded in 2025 | Varies | — |
| Wegovy Covered in 13 states (CA, CT, DE, MA, MI, MN, MO, NJ, NY, OR, PA, RI, VA) with PA | Varies | — |
Look up your specific plan ID for plan-level accuracy. Open formulary tool
Coverage shown is a sample plan and not a guarantee for your specific Medicaid (national overview) plan. Always verify with member services or your benefits administrator. We update this page when formulary changes are detected — last verified May 16, 2026.
Looking for a specific medication? Browse all GLP-1 reviews →